UroGen Pharma URGN
NASDAQ URGN
$35.48 +0.47 (+1.34%)
At close: Oct 21, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Current Leases (2025 - 2026)

Updated

UroGen Pharma's Current Leases came in at $1.41 million for Q2 2026.

Analysis

UroGen Pharma (URGN) Current Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, UroGen Pharma's Current Leases was $1.27 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 UroGen Pharma 1.79 Bn 1.29 Bn 65.88 Mn 1.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.41 Mn
Dec 31, 2025 1.27 Mn
API Access

UroGen Pharma Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=URGN&period=max&api_key=YOUR_API_KEY